Everolimus May Help Shrink Kidney Tumors in TSC Patients

Share this content:

A new international study has found that everolimus may help successfully shrink agiomyolipomas (AMLs) in patients with tuberous sclerosis complex (TSC). John Schieszer reports in today's Medical Minute that this agent may substantially reduce the size of kidney tumors in a substantial number in patients with TSC.
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters